ECTRIMS eLearning

Concomitant use of quantitative magnetization transfer and susceptibility mapping in longitudinal study of early multiple sclerosis patients
Author(s): ,
O Mougin
Affiliations:
SPMIC, School of Physics and Astronomy, University of Nottingham
,
A Samaraweera
Affiliations:
Department of Clinical Neurology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom
,
N Geades
Affiliations:
SPMIC, School of Physics and Astronomy, University of Nottingham
,
M Cronin
Affiliations:
Brain Imaging and Analysis Centre, Duke University, Durham, NC, United States
,
P Gowland
Affiliations:
SPMIC, School of Physics and Astronomy, University of Nottingham
N Evangelou
Affiliations:
Department of Clinical Neurology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom
ECTRIMS Learn. MOUGIN O. 09/16/16; 145722; P1038
Dr. Olivier MOUGIN
Dr. Olivier MOUGIN
Contributions
Abstract

Abstract: P1038

Type: Poster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Purpose: Myelin evolution of Multiple Sclerosis (MS) lesion can be monitored via MRI by using the traditional Magnetization Transfer Ration (MTR). However, inflammation, oedema and axonal loss together with myelination influence the MTR. Quantitative Magnetization Transfer (qMT) measure macromolecules content independently from T1 change due to oedema or inflammation. It can be measured via Chemical Exchange Saturation Transfer (CEST), and can be used to monitor accurately myelination changes inside and at the rim of the lesion taking into account the water content of the tissue. Recently susceptibility of the tissue, quantified by Quantitative Susceptibility Mapping (QSM) and indicating iron concentration, also showed evolution at the edge as well as inside the lesion during its formation. Here we present a longitudinal MS study aimed at tracking and quantifying lesion evolution with qMT together with QSM data.

Methods: With ethics approval, 4 patients with early Multiple Sclerosis were scanned 6 times with 6 weeks between scans (30 weeks total) using a 7T MRI. Imaging protocol includes Quantitative MT derived from CEST data as well as QSM derived from multi-echo T2star, standard FLAIR and PSIR images. FLAIR images were used to track MS lesions and create masks for ROI processing. Mean percentage MT pool sizes and susceptibility in an ROI drawn where white matter (WM) lesions appeared during the 30 weeks, were compared to regions of normal appearing WM close to the lesion site.

Results: We detected demyelination and remyelination as seen by changes of qMT in acute lesions as reported before. In addition we found a correlation of qMT with QSM inside the lesions both in crossectional analysis (r=-0.31, p=1e-9). The correlation in lesions was stronger than in the normal appearing tissue (r=-0.14, p=1e-9). However when the rim of acute lesions were studied we detected loss of qMT with initially associated loss of QSM. QSM increased signal appeared within 6 weeks. The differential appearance of QSM and qMT rings in acute lesions suggests degradation of myelin first and local accumulation of iron as a secondary effect.

Conclusion: Concomitant use of QSM and qMT concentration measurements appear to provide additional information about pathological changes in white matter lesions in MS and show promise for the study of early evolution of MS lesions.

Disclosure: Olivier Mougin: nothing to disclose

Amal Samaraweera: nothing to disclose

Nicolas Geades: nothing to disclose

Matthew Croning: nothing to disclose

Penny Gowland: nothing to disclose

Nikos Evangelou: nothing to disclose

Abstract: P1038

Type: Poster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Purpose: Myelin evolution of Multiple Sclerosis (MS) lesion can be monitored via MRI by using the traditional Magnetization Transfer Ration (MTR). However, inflammation, oedema and axonal loss together with myelination influence the MTR. Quantitative Magnetization Transfer (qMT) measure macromolecules content independently from T1 change due to oedema or inflammation. It can be measured via Chemical Exchange Saturation Transfer (CEST), and can be used to monitor accurately myelination changes inside and at the rim of the lesion taking into account the water content of the tissue. Recently susceptibility of the tissue, quantified by Quantitative Susceptibility Mapping (QSM) and indicating iron concentration, also showed evolution at the edge as well as inside the lesion during its formation. Here we present a longitudinal MS study aimed at tracking and quantifying lesion evolution with qMT together with QSM data.

Methods: With ethics approval, 4 patients with early Multiple Sclerosis were scanned 6 times with 6 weeks between scans (30 weeks total) using a 7T MRI. Imaging protocol includes Quantitative MT derived from CEST data as well as QSM derived from multi-echo T2star, standard FLAIR and PSIR images. FLAIR images were used to track MS lesions and create masks for ROI processing. Mean percentage MT pool sizes and susceptibility in an ROI drawn where white matter (WM) lesions appeared during the 30 weeks, were compared to regions of normal appearing WM close to the lesion site.

Results: We detected demyelination and remyelination as seen by changes of qMT in acute lesions as reported before. In addition we found a correlation of qMT with QSM inside the lesions both in crossectional analysis (r=-0.31, p=1e-9). The correlation in lesions was stronger than in the normal appearing tissue (r=-0.14, p=1e-9). However when the rim of acute lesions were studied we detected loss of qMT with initially associated loss of QSM. QSM increased signal appeared within 6 weeks. The differential appearance of QSM and qMT rings in acute lesions suggests degradation of myelin first and local accumulation of iron as a secondary effect.

Conclusion: Concomitant use of QSM and qMT concentration measurements appear to provide additional information about pathological changes in white matter lesions in MS and show promise for the study of early evolution of MS lesions.

Disclosure: Olivier Mougin: nothing to disclose

Amal Samaraweera: nothing to disclose

Nicolas Geades: nothing to disclose

Matthew Croning: nothing to disclose

Penny Gowland: nothing to disclose

Nikos Evangelou: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies